News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

NIR Diagnostics (NID.V) Completes Internal Testing of OmegaNIR(TM)



6/4/2008 4:17:38 PM

CAMPBELLVILLE, ON, June 4 /CNW/ - NIR Diagnostics Inc. (TSX Venture: NID), an innovator in the development of in-vitro and in-vivo medical diagnostic devices today announced that it has successfully completed internal testing of its in-vivo light-based platform for an application that monitors levels of omega-6 and omega-3 fatty acids non-invasively. The portable OmegaNIR(TM) device has been developed on the Company's VisionNIR(TM) platform which allows a user to monitor blood and tissue with the use of near-infrared light. This eliminates the need to secure a blood sample for expensive and time consuming laboratory tests. NIR Diagnostics plans to initiate live patient testing of cardiac patients at cardiac clinics in Los Angeles County, California.

Read at Canada NewsWire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES